<SEC-DOCUMENT>0001104659-23-065478-index.html : 20230526
<SEC-HEADER>0001104659-23-065478.hdr.sgml : 20230526
<ACCEPTANCE-DATETIME>20230526161740
ACCESSION NUMBER:		0001104659-23-065478
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230526
DATE AS OF CHANGE:		20230526
GROUP MEMBERS:		NOVARTIS AG

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gamida Cell Ltd.
		CENTRAL INDEX KEY:			0001600847
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90706
		FILM NUMBER:		23969159

	BUSINESS ADDRESS:	
		STREET 1:		5 NAHUM HAFZADI STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			95484
		BUSINESS PHONE:		97226595666

	MAIL ADDRESS:	
		STREET 1:		5 NAHUM HAFZADI STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			95484

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS PHARMA AG
		CENTRAL INDEX KEY:			0001030617

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8
		BUSINESS PHONE:		212-830-2474

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVARTIS INC
		DATE OF NAME CHANGE:	19970114
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>tm2316996d1_sc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
Document 1 - file: tm2316996d1_sc13da.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>2
<FILENAME>tm2316996d1_ex4.htm
<DESCRIPTION>EXHIBIT 4
<TEXT>
Document 2 - file: tm2316996d1_ex4.htm

</DOCUMENT>
</SEC-DOCUMENT>